BISAF COMBO 6in1 test | SARS-CoV-2 | Influenza A+B | RSV | Adenovirus | Mycoplasma | 20 pieces

• sample material: nasal swab, nasopharyngeal swab
• painless sample collection
• high-quality product
• rapid results in just 15 minutes
• bulk packaging of 20 pieces
• intended for professional use

Test specification

• SARS-CoV-2: specificity: 99,72%, sensitivity: 98,11%, accuracy: 99,13%
• Influenza A: specificity: 92,52%, sensitivity: 95,52%, accuracy: 92,95%
• Influenza B: specificity: 99,89%, sensitivity: 91,86%, accuracy: 99,53%
• RSV: specificity: 99,39%, sensitivity: 97,79%, accuracy: 98,93%
• Adenovirus: specificity: 99,09%, sensitivity: 97,39%, accuracy: 98,65%
• Mycoplasma pneumoniae: specificity: 99,09%, sensitivity: 96,19%, accuracy: 98,39%

The package contains

• 20 test cassettes
• 40 single-use sterile swabs
• 20 extraction buffers
• 2 tube stands
• 1 user manual

Test application

• The test is intended for the qualitative assessment of infections caused by SARS-CoV-2, influenza virus types A and B, respiratory syncytial virus (RSV), adenovirus (ADV), and the bacterium Mycoplasma pneumoniae. It enables the rapid detection or exclusion of the cause of a patient’s symptoms.
• The test is especially recommended for pediatricians and general practitioners, as these pathogens are common causes of respiratory tract infections in both children and adults. The painless collection of a nasal swab sample makes the procedure well tolerated even by the youngest patients.
• The test can be used for differential diagnosis of viral and bacterial infections in outpatient settings, hospitals, and primary healthcare facilities. It allows for quick confirmation or exclusion of infection with one of the six most frequent respiratory pathogens, supporting accurate clinical decision-making.

Product Identification Data and Responsible Entities

EAN Code: 6933289838115